Sort
46,585 grants matching “heart failure”
Exploring pathophysiologic mechanisms to assess risk and optimize treatment outcomes in patients with mitral regurgitation
$4,066,506Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai · U01 · FY2023 · HL
SSCOR in Pediatric Heart Development and Disease
$4,048,278Jane W. Newburger · Boston Children'S Hospital · P50 · FY2006 · HL
Healthy Aging In Neighborhoods of Diversity Across the Life Span (HANDLS)
$4,045,111Michele K Evans · National Institute On Aging · ZIA · FY2015 · AG
Framingham Project/Levy
$4,038,033Daniel Levy · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
OCCLUDED ARTERY TRIAL--CLINICAL COORDINATING CENTER
$4,022,887St. Luke'S-Roosevelt Inst For Hlth Scis · U01 · FY2000 · HL
BIOMEDICAL (BASIC)
$4,011,942David Goff · Wake Forest University Health Sciences · N01 · FY2013 · HL
Healthy Aging In Neighborhoods of Diversity Across the Life Span (HANDLS)
$4,011,599Michele K Evans · National Institute On Aging · ZIA · FY2020 · AG
PROMISE Trial: Clinical Coordinating Center
$4,000,000Pamela Susan Douglas · Duke University · R01 · FY2012 · HL
Insulin Resistance Intervention after Stroke (IRIS) Trial
$4,000,000Walter N Kernan · Yale University · U01 · FY2011 · NS
Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial
$4,000,000Andrew G. Bostom · Rhode Island Hospital · U01 · FY2008 · DK
Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial
$4,000,000Andrew G. Bostom · Rhode Island Hospital · U01 · FY2009 · DK
Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial
$4,000,000Andrew G. Bostom · Rhode Island Hospital · U01 · FY2007 · DK
SSCOR in Pediatric Heart Development and Disease
$3,994,916Children'S Hospital Boston · P50 · FY2004 · HL
BIOMEDICAL (BASIC) Systolic Blood Pressure Intervention Trial (SPRINT)
$3,990,712Alfred Cheung · University Of Utah · N01 · FY2015 · HL
BRIDGE TRIAL
$3,963,283Thomas L Ortel · Duke University · U01 · FY2008 · HL
Genetic and Molecular Signaling in Heart Failure
$3,958,730Evangelia G Kranias · University Of Cincinnati · P50 · FY2009 · HL
Disease Status Drug Metabolism and New Drug Discovery
$3,957,647Irving William Wainer · National Institute On Aging · ZIA · FY2014 · AG
TAS::75 0872:: TAS INTERMACS RENEWAL
$3,941,360Timothy Parker · University Of Alabama At Birmingham · N01 · FY2012 · HL
The ISCHEMIA Trial - SDCC
$3,933,889Sean M O'Brien · Duke University · U01 · FY2012 · HL
SSCOR in Pediatric Heart Development and Disease
$3,928,549Jane W. Newburger · Boston Children'S Hospital · P50 · FY2007 · HL
BIOMEDICAL (BASIC) Systolic Blood Pressure Intervention Trial (SPRINT)
$3,925,615Alfred Cheung · University Of Utah · N01 · FY2014 · HL
A 3-D biomimetic human islet to model beta cell function in health and disease
$3,913,839Maike Sander · University Of California, San Diego · UC4 · FY2014 · DK
Rare variants and NHLBI traits in deeply phenotyped cohorts
$3,896,325Bruce M Psaty · University Of Washington · U01 · FY2017 · HL
1/2 PREEMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
$3,886,403Neha Jadeja Pagidipati · Duke University · UG3 · FY2025 · HL
Framingham Project/Levy
$3,878,704Daniel Levy · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL